These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 5165302

  • 1. Reversal of the reserpine syndrome with L-dopa metabolites in reserpinized rats.
    Ericsson AD, Wertman BG, Duffy KM.
    Neurology; 1971 Oct; 21(10):1023-9. PubMed ID: 5165302
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Central and peripheral catecholamine turnover studied by means of 3H-DOPA and 3H-tyrosine.
    Persson T.
    Acta Pharmacol Toxicol (Copenh); 1969 Oct; 27(6):397-409. PubMed ID: 5395728
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recent advances in the treatment of Parkinsonism with drugs.
    Rinne UK.
    Acta Neurol Scand Suppl; 1972 Oct; 51():59-103. PubMed ID: 4576076
    [No Abstract] [Full Text] [Related]

  • 11. Some biochemical and behavioural correlates of a possible animal model of human hyperkinetic syndromes.
    McKenzie GM, Gordon RJ, Viik K.
    Brain Res; 1972 Dec 12; 47(2):439-56. PubMed ID: 4404908
    [No Abstract] [Full Text] [Related]

  • 12. [Problems and therapy of L-DOPA-induced dyskinesias].
    Völler GW, Deze J, Gundlach U, Muschard F.
    Nervenarzt; 1972 Nov 12; 43(11):584-6. PubMed ID: 4564994
    [No Abstract] [Full Text] [Related]

  • 13. [Abnormal movements induced by L-Dopa and dopamine metabolism disorders].
    Lhermitte F, Rosa A, Comoy E, Bohuon C.
    Rev Neurol (Paris); 1973 Dec 12; 129(6):313-24. PubMed ID: 4794176
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. L-Dopa in the treatment of parkinsonism.
    Calne DB.
    Clin Pharmacol Ther; 1970 Dec 12; 11(6):789-801. PubMed ID: 4921292
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical study of L-dopa in Parkinson's disease].
    Franken L, Noel G, Lhoas JP, Meyers C, Noel P, Ectors M.
    Brux Med; 1972 Dec 12; 52(12):851-60. PubMed ID: 4575350
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.